OUSW Drug Demand Reduction Quality Assurance Services

The Washington Headquarters Services/Acquisition Directorate is conducting market research to identify potential sources for Quality Assurance Services supporting a Drug Demand Reduction Program. This effort is being undertaken through a Sources Sought Notice/Request for Information and is strictly for information gathering, not a solicitation for proposals or bids. The associated Draft Performance Work Statement outlines the scope and requirements of the services sought, emphasizing that there is no current obligation to procure or contract. The project, titled "OUSW Drug Demand Reduction Quality Assurance Services," is identified under solicitation number DB052920261012, with responses due by June 30, 2026. It falls under NAICS code 541380, which pertains to testing laboratories, indicative of the technical and evaluative nature of the quality assurance work. The contracting office is located in Washington, DC, under the Department of Defense, with primary contacts Syreeta Donald and Daniel Baskin available to provide further information. The posting serves as a preliminary step to engage industry feedback and assess market capabilities before any formal acquisition process is initiated.